跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Xanpurin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Xanpurin
Approved
STANDARD
Xanpurin
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
3e14e0641159bf9c
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
3e14e0641159bf9c
Drug Approval Philippines Name
Xanpurin
Product Name
Xanpurin
Registration Number
DR-XY25636
Brand Name
Xanpurin
Generic Name
Allopurinol
Dosage Form
Tablet
Dosage Strength
300 mg
Manufacturer
Lloyd Laboratories, Inc.
Trader
Corbridge Group Phils. Inc.
Issuance Date
25 June 2024
Expiry Date
04 November 2029
Pharmacologic Category
Antigout
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
3e14e0641159bf9c
Type
Standard
Back to Philippines FDA Approvals